Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,503
Closed -$800K 310
2026
Q1
$800K Sell
8,503
-455
-5% -$45.4K 0.01% 315
2025
Q4
$885K Sell
8,958
-10
-0.1% -$968 0.02% 290
2025
Q3
$761K Buy
8,968
+170
+2% +$13.4K 0.02% 286
2025
Q2
$599K Buy
+8,798
New +$557K 0.01% 311
2022
Q4
Sell
-200
Closed -$13K 737
2022
Q3
$13K Sell
200
-50
-20% -$3.69K ﹤0.01% 710
2022
Q2
$19K Buy
250
+20
+9% +$1.52K ﹤0.01% 653
2022
Q1
$18K Buy
230
+87
+61% +$6.33K ﹤0.01% 672
2021
Q4
$10K Hold
143
﹤0.01% 788
2021
Q3
$9K Hold
143
﹤0.01% 760
2021
Q2
$12K Sell
143
-12
-8% -$1K ﹤0.01% 724
2021
Q1
$13K Hold
155
﹤0.01% 648
2020
Q4
$13K Hold
155
﹤0.01% 543
2020
Q3
$14K Sell
155
-229
-60% -$22.1K ﹤0.01% 519
2020
Q2
$40K Buy
384
+226
+143% +$21.8K ﹤0.01% 375
2020
Q1
$11.6K Buy
+158
New +$11.9K ﹤0.01% 491
2019
Q4
Sell
-208
Closed -$15.4K 1334
2019
Q3
$15.4K Buy
+208
New +$16.8K ﹤0.01% 725

Other funds holding INCY

Evoke Wealth's INCY Position: Q2 2026 in Review

Evoke Wealth sold out of Incyte (INCY) in Q2 2026, closing a stake of 8,503 shares — an estimated $800K sold.

Evoke Wealth first reported a position in INCY in Q3 2019 and held it in 16 quarters. The position peaked at $885K in Q4 2025. 853 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Evoke Wealth reported no remaining Incyte position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 8,503 Incyte shares in Q2 2026, an estimated $800K.
  • Evoke Wealth first reported a position in Incyte in Q3 2019 and held it in 16 quarters.
  • Evoke Wealth's Incyte position peaked at $885K in Q4 2025.
  • 853 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.